Dr Reddys Laboratories (RDY) Cash from Operations (QoQ) (2009 - 2025)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Cash from Operations (QoQ) (2009 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.91 Bn | 2.15 Bn |
| 2 | Viatris | 19.14 Bn | 18.26 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.89 Bn | 9.71 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 994.43 Mn | 704.31 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 401.07 Mn | 359.82 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 179.86 Mn | 179.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 4.46% |
| Sep 30, 2024 | 9.21% |
| Jun 30, 2024 | -26.58% |
| Mar 31, 2024 | 143.83% |
| Dec 31, 2023 | -73.76% |
| Sep 30, 2023 | 58.36% |
| Jun 30, 2023 | -42.80% |
| Mar 31, 2023 | -15.50% |
| Dec 31, 2022 | 143.37% |
| Sep 30, 2022 | 34.88% |
| Jun 30, 2022 | -28.83% |
| Mar 31, 2022 | -47.57% |
| Dec 31, 2021 | 235.66% |
| Sep 30, 2021 | 247.37% |
| Jun 30, 2021 | -130.26% |
| Mar 31, 2021 | 167.26% |
| Dec 31, 2020 | -53.47% |
| Sep 30, 2020 | -13.42% |
| Jun 30, 2020 | 308.36% |
| Mar 31, 2020 | -65.96% |